Sanofi (MEX:SNY) FCF Yield % : 3.76 (As of Dec. 14, 2024)

View and export this data going back to 2009. Start your Free Trial

What is Sanofi FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Sanofi's Trailing 12-Month Free Cash Flow is MXN77,196 Mil, and Market Cap is MXN2,367,264 Mil. Therefore, Sanofi's FCF Yield % for today is 3.76%.

The historical rank and industry rank for Sanofi's FCF Yield % or its related term are showing as below:

MEX:SNY' s FCF Yield % Range Over the Past 10 Years
Min: 3.15 Med: 5.83 Max: 8.6
Current: 3.76

During the past 13 years, the highest FCF Yield % of Sanofi was 8.60%. The lowest was 3.15%. And the median was 5.83%.

MEX:SNY's FCF Yield % is ranked better than
73.6% of 1038 companies
in the Drug Manufacturers industry
Industry Median: 0.115 vs MEX:SNY: 3.76

Sanofi's FCF Margin % for the quarter that ended in Jun. 2024 was -2.06%.

Sanofi FCF Yield % Historical Data

The historical data trend for Sanofi's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sanofi FCF Yield % Chart

Sanofi Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Yield %

Get a 7-Day Free Trial

6.23

5.37

7.62

7.29

6.40

Sanofi Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
FCF Yield %	Get a 7-Day Free Trial															4.79	9.59	4.23	8.14	-0.82

Competitive Comparison of Sanofi's FCF Yield %

For the Drug Manufacturers - General subindustry, Sanofi's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sanofi's FCF Yield % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Sanofi's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Sanofi's FCF Yield % falls into.

Sanofi FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Sanofi's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	133905.9	/	2092257.2
	=	6.40%

Sanofi's annualized FCF Yield % for the quarter that ended in Jun. 2024 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	-9130.471	*	2	/	2226332.988
	=	-0.82%

Sanofi FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Sanofi FCF Yield % Related Terms

Thank you for viewing the detailed overview of Sanofi's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Sanofi Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sanofi SA (MEX:SNY) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

SNYNF:USA SNY:USA 1SAN:Italy SANp:UK 0O59:UK SAN:France SNW:Germany SNW:Germany SNW:Germany SNW2:Germany SNW:Germany SNW:Bulgaria SANO:Austria

Address

46, avenue de la Great Army, Paris, FRA, 75017

Website

https://www.sanofi.com

Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, over-the-counter treatments and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 20% of total sales, but profits are shared with Regeneron. Just over 40% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.